Search results
Results From The WOW.Com Content Network
Green received his B.S. degree in bacteriology from the University of Wisconsin–Madison in 1981 and his M.D. and Ph.D. degrees from Washington University in 1987. [6] During residency training in clinical pathology (laboratory medicine), he worked in the laboratory of Maynard Olson , where he launched his career in genomics research.
All NIH Institutes and Centers are involved with OSC in the design, implementation, and evaluation of Common Fund programs. [15] commonfund.nih.gov: Office of Technology Transfer: OTT manages the wide range of NIH and FDA intramural inventions as mandated by the Federal Technology Transfer Act and related legislation.
September 1993—The NIH Revitalization Act of 1993 (P.L. 103-43) directed NIAMS to establish "an information clearinghouse on osteoporosis and related bone disorders to facilitate and enhance knowledge and understanding on the part of health professionals, patients, and the public through the effective dissemination of information."
Get ready for all of today's NYT 'Connections’ hints and answers for #581 on Sunday, January 12, 2025. Today's NYT Connections puzzle for Sunday, January 12, 2025 The New York Times
Get ready for all of today's NYT 'Connections’ hints and answers for #554 on Monday, December 16, 2024. Today's NYT Connections puzzle for Monday, December 16, 2024The New York Times
Get ready for all of today's NYT 'Connections’ hints and answers for #479 on Wednesday, October 2, 2024. Today's NYT Connections puzzle for Wednesday, October 2, 2024 The New York Times
The NIH Office of Science Policy works on a wide range of issues including biosafety, [2] biosecurity, [3] genetic testing, genomic data sharing, [4] human subjects protections, [5] the organization and management of the NIH, and the outputs and value of NIH-funded research. This is accomplished through a wide range of analyses and reports ...
As of 2011, NIH-supported research helped to discover 153 new FDA-approved drugs, vaccines, and new indications for drugs in the 40 years prior. [35] One study found NIH funding aided either directly or indirectly in developing the drugs or drug targets for all of the 210 FDA-approved drugs from 2010 to 2016. [36]